This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Down -16.79% in 4 Weeks, Here's Why You Should You Buy the Dip in MeridianLink (MLNK)
by Zacks Equity Research
The heavy selling pressure might have exhausted for MeridianLink (MLNK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
CPI Card Group Inc. (PMTS) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
CPI Card Group Inc. (PMTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: MeridianLink (MLNK) Q4 Earnings Expected to Decline
by Zacks Equity Research
MeridianLink (MLNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Holdings Ltd. (NU) Misses Q4 Earnings Estimates
by Zacks Equity Research
Nu Holdings Ltd. (NU) delivered earnings and revenue surprises of -11.11% and 0.63%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Down -14.79% in 4 Weeks, Here's Why You Should You Buy the Dip in MeridianLink (MLNK)
by Zacks Equity Research
MeridianLink (MLNK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down -17.27% in 4 Weeks, Here's Why MeridianLink (MLNK) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for MeridianLink (MLNK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
MeridianLink (MLNK) Q3 Earnings Surpass Estimates
by Zacks Equity Research
MeridianLink (MLNK) delivered earnings and revenue surprises of 100% and 0.59%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
MeridianLink (MLNK) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
MeridianLink (MLNK) delivered earnings and revenue surprises of -50% and 2.38%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in MeridianLink (MLNK) Stock?
by Zacks Equity Research
Investors need to pay close attention to MeridianLink (MLNK) stock based on the movements in the options market lately.
MeridianLink (MLNK) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
MeridianLink (MLNK) delivered earnings and revenue surprises of -25% and 2.45%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Vontier Corporation (VNT) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Vontier Corporation (VNT) delivered earnings and revenue surprises of -1.15% and 3.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Accolade (ACCD) delivered earnings and revenue surprises of 7.04% and 5.68%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include JDefinitive Healthcare, Cinemark Holdings, MeridianLink and Spirit AeroSystems
by Zacks Equity Research
JDefinitive Healthcare, Cinemark Holdings, MeridianLink and Spirit AeroSystems are part of Zacks Screen of the Week article.
4 Toxic Stocks That May Give You a Tough Time
by Rimmi Singhi
Accurately identifying toxic stocks and getting rid of them at the right time can protect your portfolio. It's time to cut ties with toxic stocks like DH, CNK, MLNK and SPR.
MeridianLink (MLNK) Q2 Earnings Meet Estimates
by Zacks Equity Research
MeridianLink (MLNK) delivered earnings and revenue surprises of 0% and 0.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Telus International (TIXT) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Telus (TIXT) delivered earnings and revenue surprises of 7.14% and 0.74%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Confluent (CFLT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Confluent (CFLT) delivered earnings and revenue surprises of 15.79% and 6.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
VSTA vs. MLNK: Which Stock Is the Better Value Option?
by Zacks Equity Research
VSTA vs. MLNK: Which Stock Is the Better Value Option?
VSTA vs. MLNK: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
VSTA vs. MLNK: Which Stock Is the Better Value Option?